γ-CUBE for preclinical SPECT imaging completing PET PET CT setup at KU Leuven, Belgium.
The Molecular Small Animal Imaging Center core facility (MoSAIC) at KU Leuven has further expanded its preclinical imaging capabilities with the addition of a γ-CUBE to the existing state-of-the-art in vivo imaging PET PET CT platform from MOLECUBES. The addition of this preclinical SPECT imaging capability enables novel, groundbreaking research using isotopes such as Tb161, In111 and Tc99m. These isotopes will enable MoSAIC to track both small and large molecules over a longer period of time as well as open up new possibilities to study the enhancement of therapeutic efficacy of various tumour targeting carriers. In combination with the extensive expertise for the non-invasive and longitudinal assessment of preclinical disease and therapy models at MoSAIC, this will generate new insights for improved therapy outcome and understanding of disease.